Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

992
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
992

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mining and analysis of drug-induced shock adverse reactions: A comprehensive pharmacovigilance study based on the US FAERS database.

PloS one·2025
Same author

Letter to the editor: "Incidence of kidney toxicity of non-steroidal anti-inflammatory drugs in critically ill patients".

Journal of critical care·2025
Same author

Efficiency and mechanism of sorption of low concentration uranium in water by powdery aerobic activated sludge.

Ecotoxicology and environmental safety·2019
Same author

Severe thoracic trauma caused left pneumonectomy complicated by right traumatic wet lung, reversed by extracorporeal membrane oxygenation support-a case report.

BMC pulmonary medicine·2019
Same author

The safety and efficacy of daptomycin versus other antibiotics for skin and soft-tissue infections: a meta-analysis of randomised controlled trials.

BMJ open·2014

Related Experiment Video

Updated: Jan 10, 2026

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
11:02

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics

Published on: November 29, 2024

1.0K

Mining and analysis of reported ARDS population in FAERS database.

Jun Hua Lai1,2, Yi Ping Pan1, Zhi Hui Yu1

  • 1The First Affiliated Hospital of Guangxi Medical University, Nan Ning, GuangXi, China.

Plos One
|November 24, 2025
PubMed
Summary

Drug-induced acute respiratory distress syndrome (ARDS) is a severe adverse drug reaction. This study identified patient profiles and risk factors, emphasizing the need for enhanced drug safety surveillance.

More Related Videos

The Application of Point-of-Care Ultrasonography (POCUS) in the Management of Acute Respiratory Distress Syndrome (ARDS) in the Intensive Care Unit
08:22

The Application of Point-of-Care Ultrasonography (POCUS) in the Management of Acute Respiratory Distress Syndrome (ARDS) in the Intensive Care Unit

Published on: December 12, 2025

736
Invasive Hemodynamic Monitoring of Aortic and Pulmonary Artery Hemodynamics in a Large Animal Model of ARDS
08:12

Invasive Hemodynamic Monitoring of Aortic and Pulmonary Artery Hemodynamics in a Large Animal Model of ARDS

Published on: November 26, 2018

10.5K

Related Experiment Videos

Last Updated: Jan 10, 2026

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
11:02

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics

Published on: November 29, 2024

1.0K
The Application of Point-of-Care Ultrasonography (POCUS) in the Management of Acute Respiratory Distress Syndrome (ARDS) in the Intensive Care Unit
08:22

The Application of Point-of-Care Ultrasonography (POCUS) in the Management of Acute Respiratory Distress Syndrome (ARDS) in the Intensive Care Unit

Published on: December 12, 2025

736
Invasive Hemodynamic Monitoring of Aortic and Pulmonary Artery Hemodynamics in a Large Animal Model of ARDS
08:12

Invasive Hemodynamic Monitoring of Aortic and Pulmonary Artery Hemodynamics in a Large Animal Model of ARDS

Published on: November 26, 2018

10.5K

Area of Science:

  • Pharmacovigilance and Drug Safety
  • Critical Care Medicine
  • Respiratory Medicine

Background:

  • Drug-induced acute respiratory distress syndrome (ARDS) is a severe adverse drug reaction with significant patient safety implications.
  • The pathophysiology involves inflammation, endothelial dysfunction, and increased vascular permeability, leading to pulmonary edema.
  • Comprehensive analyses of large-scale databases for drug-induced ARDS are underexplored.

Purpose of the Study:

  • To analyze the FDA Adverse Event Reporting System (FAERS) database for drug-induced ARDS.
  • To identify demographic and clinical profiles of patients experiencing these adverse drug events (ADEs).
  • To assess the incidence and outcomes of drug-induced ARDS.

Main Methods:

  • Utilized FAERS data from Q1 2004 to Q4 2024.
  • Preprocessed data including deduplication and standardization using MedDRA and WHO Drug Dictionaries.
  • Conducted disproportionality analyses (ROR, PRR, Chi-Square, IC, EBGM) to detect ADE signals.

Main Results:

  • Analyzed 18,613,992 patients, with 15,986 experiencing targeted ADEs.
  • 46.69% male, 42.81% female; median age 55; 26.01% aged 65+.
  • High rates of severe outcomes: 65.04% hospitalization, 51.21% death, 30.64% life-threatening; median onset 19 days.

Conclusions:

  • Drug-induced ARDS necessitates continuous pharmacovigilance and timely intervention.
  • Findings offer insights into patient demographics and clinical profiles for ADE management.
  • Further research on risk factors, mechanisms, and long-term outcomes is crucial for patient safety.